Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast foam in seborrheic dermatitis
NCT04973228Phase 3Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Jul 2021
- Primary completion
- Apr 2022
- Countries
- 2
01
Overview
A Phase 3 trial of roflumilast vehicle cream in seborrheic dermatitis (SD), sponsored by Arcutis Biotherapeutics. Started Jul 2021; status: completed.
02
Drugs
roflumilast vehicle cream
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT04973228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04973228.